HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Feinstein Bill Lacks ‘Crucial’ National Uniformity Assurance – ICMAD

This article was originally published in The Rose Sheet

Executive Summary

Small-business trade group the Independent Cosmetic Manufacturers and Distributors says the Personal Care Products Safety Act would place an undue burden on small businesses and fails to address national uniformity issues. In an interview with “The Rose Sheet,” ICMAD President and CEO Pam Busiek discussed the group’s opposition to the bill and suggested that 2012’s Cosmetic Safety Amendments Act would have been a better starting point for legislation.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts